Cumberland Pharmaceuticals Inc. Other Non-Current Liabilities
Cumberland Pharmaceuticals Inc. (CPIX) had Other Non-Current Liabilities of $3.98 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Noncurrent $3.98M.
- 2026-03-31: Other Liabilities, Noncurrent $5.62M.
- 2025-12-31: Other Liabilities, Noncurrent $3.63M; Other Liabilities, Noncurrent as first filed $5.82M.
- 2025-09-30: Other Liabilities, Noncurrent $5.95M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $3.98M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $5.62M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $3.63M 10-Q · filed 2026-08-07 | $5.82M 10-K · filed 2026-03-09 |
| 2025-09-30 | $5.95M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $6.30M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $6.01M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $6.30M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $6.09M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $6.54M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $6.61M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $6.45M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $6.46M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $6.95M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $7.09M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $7.59M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $7.49M 10-K · filed 2023-03-13 | |
| 2020-12-31 | $7.86M 10-K · filed 2022-03-11 | |
| 2019-12-31 | $8.74M 10-K · filed 2021-03-12 | |
| 2018-12-31 | $9.32M 8-K · filed 2020-12-10 | |
| 2017-12-31 | $1.82M 10-K · filed 2019-03-12 | |
| 2016-12-31 | $1.39M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $987.43K 10-K · filed 2017-03-13 | |
| 2014-12-31 | $902.84K 10-K · filed 2016-03-14 | |
| 2013-12-31 | $776.13K 10-K · filed 2015-03-09 | |
| 2012-12-31 | $611.93K 10-K · filed 2014-03-11 | |
| 2011-12-31 | $578.12K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |